[
    [
        {
            "time": "",
            "original_text": "30亿大品种！又一个抗感染药物通过一致性评价",
            "features": {
                "keywords": [
                    "30亿",
                    "大品种",
                    "抗感染药物",
                    "一致性评价"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "30亿大品种！又一个抗感染药物通过一致性评价",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "206家生物医药公司商誉达1544亿元 43家公司超过10亿元",
            "features": {
                "keywords": [
                    "206家",
                    "生物医药",
                    "商誉",
                    "1544亿元",
                    "43家公司",
                    "超过10亿元"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "206家生物医药公司商誉达1544亿元 43家公司超过10亿元",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "指数成分股将调整，机构紧盯套利机会",
            "features": {
                "keywords": [
                    "指数",
                    "成分股",
                    "调整",
                    "机构",
                    "套利机会"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "指数成分股将调整，机构紧盯套利机会",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 8,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]